ABSTRACT
INTRODUCTION
The α complementation of the bacterial lacZ gene (encoding β-galactosidase, or β-gal) has been studied for 30 years in prokaryotes (7) (8) (9) 17) and has recently been adapted for the use in eukaryotes (13, 15) . Two weakly complementing mutants of β-gal, ∆α and ∆ω, were used to detect interactions between cytoplasmic protein (12, 15) and membrane protein (2) in living mammalian cells. The β-gal mutants were fused to different target proteins, and the interaction of the non-β-gal portions of the chimeric proteins were found to be able to restore the complementation capacity of ∆α and ∆ω. Thus, the reconstitution of the β-gal activity was taken as an indicator of the interaction between the target proteins.
While the two-hybrid system has been widely used for exploring interactions between soluble proteins, the study of interactions between different membrane proteins and membrane proteins and their ligands has lagged behind because of the lack of robust assay methodology. We have attempted to implement a plasmid-based assay to study the interactions between G protein-coupled receptor (GPCR) using ∆α and ∆ω instead of β-gal, but we observed significant spontaneous α-complementation from the co-expressed mutants even when they were not fused to any peptides. This background signal made it difficult for the method to be employed in high-throughput applications.
Here we screened for novel β-gal deletions in living mammalian cells that could reduce such background. We discovered a pair of deletions, ∆N 11-75 and ∆C 82-1023, which showed significantly lower spontaneous complementation when co-expressed transiently in mammalian cells. This pair of deletions was first characterized using affinity peptides and the human insulin receptor (IR) as model systems to perform homodimerization studies. We then examined the dimerization state of the rat adrenergic receptor α 2 -receptor subtype α 2c AR and the rat D2 dopamine receptor (D2DR L ) using this pair of lacZ deletions. Here we found histochemical evidence that α 2c AR homodimerizes in vivo. Although different techniques have been used to examine rat D2DR L dimerization (14, 21) , we are the first to report that D2DR L forms homodimers in living mammalian cells. Our results suggest that the combination of a plasmid-based assay system with the novel lacZ deletions could provide a high-throughput system in which the interaction between different membrane receptors and its localization could be analyzed in a rapid and sensitive manner.
MATERIALS AND METHODS
Expression Plasmids Encoding for ∆ ∆N 11-30, ∆ ∆N 11-41, and ∆ ∆N 11-75 ∆N 11-41 was first cloned by the fusion of the BamHI filled-in XhoI fragment from the previously described lacZ construct pWZL ∆α into the XbaI filled-in XhoI site of the His-tagged pcDNA3.1 (Interactiva). To design the ∆N deletion mutants ∆N 11-30 and ∆N 11-75, the coding region for the construct pWZL ∆ω (15) 
Design of the pepA-∆ ∆N-and pepB-∆ ∆C Constructs
For the expression of pepA (MNEAYVHDGPVRSLN) and pepB (MKARKEAELAAATAEQ), oligonucleotides were designed with the coding sequence pepA(+) and pepA(-), and pepB(+) and pepB(-) (Interactiva) ( Table 1 ). The annealed oligonucleotide sequences expressing pepA and pepB were cloned into the bluntended EcoRV sites from His-tagged pcDNA3.1 and pcDNA3.1/Hygro(+). pepA-∆N 11-30, pepA-∆N 11-41, and pepA-∆N 11-75 were constructed by the fusion of the ApaI-XhoI fragments from the His-tagged pcDNA3.1 constructs ∆N 11-30, ∆N 11-41, and ∆N 11-75 into the ApaI-XhoI site of pepApcDNA3.1. To create the pepB-∆C constructs, pepB-∆C 46-1023 was first created by a three-fragment ligation: the vector ∆C 46-1023, which was cut with HindIII-XhoI, was ligated to both the XmaI filled-in HindIII fragment from HA-tagged pcDNA3.1/Hygro(+), which encompasses the HA-tag coding sequence, and to the EcoRI filled-in XhoI fragment encoding the pepB fusion from pepB-pcDNA3.1/Hygro(+) that was cloned immediately after the HA-tag. For the design of pepB-fused ∆C 82-1023, -∆C 148-1023, -∆C 377-1023, -∆C 653-1023, and -∆C 789-1023, the vector pepB-∆C 46-1023 was digested with XbaI filled-in XhoI to insert the fragments that were cut with the same restriction enzymes as described earlier for the design of the non pepB-∆C constructs. The coding region of rat α 2c AR was amplified from Rα 2 pRc/CMV (19) by PCR with the primers ARprim1 and ARprim2 ( Table 1 ). The PCR product was cloned in frame into the blunt-ended KpnI-XhoI site from ∆N 11-75, directly in front of the lacZ deletion mutant α 2c AR-∆N 11-75, and verified by DNA sequencing. α 2c AR-∆C 82-1023 was generated by insertion of the Hind-III-XhoI fragment from α 2c AR-∆N 11-75 into the HindIII-XhoI site of ∆C 82- 
Construction of
Rev., reverse; forw., forward. 
Cell Culture
Human embryonic kidney (HEK)-293 cells were grown in DMEM (Sigma, St. Louis, MO, USA) supplemented with 10% FBS and 1% penicillin (10 000U/mL)/streptomycin (10 000 mg/mL) at 37°C in a humidified 5% CO 2 atmosphere. Cells were seeded at a density of 2-3 × 10 5 cells per 24-well plate (Greiner).
Transient transfection was performed the following day with 0.2 pmol cDNA (individually or in combination) by using TransFast Transfection Reagent (Promega, Madison, WI, USA) according to the manufacturer's instructions. After 48 h, the cells were prepared for further experiments. All experiments were done in triplicate. The efficiency of the transfection for all constructs was found to be in similar range, as indicated by the co-transfection of a firefly luciferase plasmid.
Indigogenic X-Gal Histochemistry for β β-gal
Cells were processed as described (12) . Briefly, cells were fixed for 5 min in PBS plus 4% paraformaldehyde and rinsed in PBS before staining. Indigogenic X-gal staining was performed for 45 min to 4 h at 37°C in PBS, plus 1 mg/mL X-gal, 1 mM MgCl 2 , 5 mM K 3 Fe(CN) 6 , and 5 mM K 4 Fe(CN) 6 .
Fluorescence Microscopy
Fluorescence microscopy was performed on a Leica DM RXA microscope using a Leica 40x/1.25 oil numerical aperture. HEK-293 cells expressing EGFP-∆N 11-75, α 2c AR-EGFP-∆N 11-75, D2DR L -EGFP-∆N 11-75, IR-EGFP-∆N 11-75, Red2-∆C 82-1023, α 2c AR-Red2-∆C 82-1023, D2DR L -Red2-∆C 82-1023, and IRRed2-∆C 82-1023, individually or in combination, were grown on 24-well glass-bottomed culture plates. After 48 h, the cells were washed twice with PBS, and the subcellular distribution of chimeric-and non-chimeric EGFP and Red2 constructs were detected using single-line excitation at 488 and 558 nm. Co-localization studies of these constructs were performed using dualline switching excitation (488 nm for EGFP; 588 nm for Red2) and emission (500-550 nm GFP; 572-648 nm Cy3) filter sets, and images represented in false color using Adobe ® Photoshop ® 5.0 software.
FACS ® Analysis
After one wash with PBS, HEK-293 cells were trypsinized, pelleted, resuspended in staining medium (4% FCS, 10 mM HEPES, pH 7.3, and PBS), and adjusted to 5-10 × 10 6 cells/mL. The cell suspension (100 µL) was transferred to a Falcon 2058 tube. After the cells had been allowed to equilibrate in a water bath at 37°C for 10 min, an equal volume of pre-warmed 2 mM fluorescein di-β-D-galactopyranoside (FDG; Molecular Probes, Eugene, OR, USA) was rapidly mixed with the cell suspension. After 1 min of incubation at 37°C, the FDG loading was stopped by the addition of 2 mL ice-cold staining media containing 1 µg/mL propidium iodide (PI; Sigma), and the tube was placed on ice. The cells were left on ice for 2-3 h to allow for the enzymatic conversion of FDG to fluorescein. These samples were run on a FACScan ® Cell Analyzer (BD Biosciences, San Jose, CA, USA).
Colorimetric β β-gal Assay
HEK-293 cells were trypsinized and resuspended in medium (4% FCS, 10 mM HEPES, pH 7.3, PBS). Cells (2 × 10 5 ) were incubated with 2 mM FDG for 1 min at 37°C. The FDG loading was stopped by the addition of 2 mL ice-cold medium, and the cells were placed on ice for 3 h. After pelleting the cells, the enzymatic conversion of FDG to fluorescein was determined photometrically at 485 nm.
RESULTS AND DISCUSSION

Design and Screening of a Novel Pair of lacZ Deletions
The transient co-transfection of the previously described weakly complementing ∆α 11-41 and ∆ω 789-1023 deletion mutants (2,12,15) generated a high-background β-gal activity in HEK-293 and NIH-3T3 cells in our exResearch Report periments (data not shown). Therefore, we constructed plasmids expressing several novel amino (N)-and carboxyl (C)-terminal-deleted versions (called ∆N and ∆C) of lacZ ( Figure 1A) . Our goal was to find pairs of inactive β-gal deletion mutants that were capable of complementing one another in trans and assembling to form an active enzymatic complex only in the presence of interacting peptides. Chimeric proteins were formed between the lacZ deletions and a pair of small interacting peptides, pepA and pepB, in the first instance. The two peptides were recently isolated from a library using a λ repressor-reconstitution assay (22) and were chosen for this study because their small size could minimize the risk of influencing the protein structure of the tested lacZ deletions and avoid nonspecific β-gal activity. PepA (MNEAY-VHDGPVRSLN) was fused to the ∆N constructs ( Figure 1B) , and pepB (MKARKEAELAAATAEQ) was fused to the designed ∆C constructs.
All ∆N and ∆C constructs were transiently co-transfected pairwise into HEK-293 cells to screen for β-gal deletion mutants that displayed a low level of spontaneous complementation when co-expressed as non-chimeric proteins.
The degree of spontaneous complementation was quantified by counting the numbers of cells stained blue in the presence of X-gal. No blue-stained cells were detected for the deletion mutants ∆N 11-75 and ∆C 46-1023 when co-expressed with or without the chimeric peptides ( Figure 1C , right panel, background) because the lack of 29 amino acids prevented the formation of an active enzyme complex. The previously described weakly complementing deletion mutants ∆α 11-41 and ∆ω 789-1023 showed a high level of β-gal activity with more than 400 X-gal-positive cells in this assay, even with no Research Report chimeric peptides. Only a novel pair of lacZ deletions, ∆N 11-75 and ∆C 82-1023, were found to fulfill our selection criteria: the lowest background when co-expressed as non-fusion proteins and high signal when fused with interacting peptides. For ∆N 11-75 and ∆C 82-1023, fewer than 10 blue cells were observed when the lacZ deletions were not fused to the peptides, whereas 30 times more blue cells were found when the lacZ deletions were attached to the pepA and pepB ( Figure 1C, left panel) . Note that all deletions could find at least one complementation partner. This proved that none of the deletions was deficient in accumulation ( Figure 1C ).
Induction of β β-gal Activity on Co-Expressed IR when Fused to the Deletions ∆ ∆N 11-75 and ∆ ∆C 82-1023
We first chose IR to test the applicability of our novel lacZ deletions in the study of membrane protein interaction because it is known that IR, a tyrosine kinase, is internalized as a dimer at the cell surface (6, 16, 18) . HEK-293 cells were co-transfected with equimolar amounts of IR-∆N 11-75 and IR-∆C 82-1023 simultaneously or individually, and then X-gal staining was used to visualize the reconstitution of the β-gal activity. The results showed a high proportion of blue-stained cells when both chimeric receptors were co-transfected, indicating that they interacted with each other (Figure 2A ). In comparison, only a few cells were X-gal-positive when both constructs ∆N 11-75 and ∆C 82-1023 were co-expressed as non-fusion proteins ( Figure 2B ). In cells that expressed only one of the two chimeric constructs, no β-gal activity could be detected (Figure 2, C and D) . These results were corroborated by the FACS analysis of the cell populations co-expressed with IR-fused ∆N 11-75 and ∆C 82-1023 construct pair and, as negative controls, the non-fused proteins ∆N 11-75 and ∆C 82-1023 pair ( Figure  2E ). IR-fused and non-fused ∆α 11-41 and ∆ω 789-1023 construct pairs were also included for a comparison ( Figure  2F ). The assay clearly showed a much higher β-gal activity for the IR-fused ∆N 11-75 and ∆C 82-1023 construct pair compared to the non-fused proteins ∆N 11-75 and ∆C 82-1023 pair, in which the peak overlapped completely with the peak generated by untransfected cells (data not shown). The β-gal activity was not significantly different between the cells that were co-transfected IR-fused and non-fused ∆α 11-41 and ∆ω 789-1023 construct pairs.
To verify the localization of the fusion proteins, IR-∆N 11-75 was further fused to the EGFP derived from Aequorea victoria, whereas IR-∆C 82-1023 was further fused to the red fluorescent protein (Red2) derived from Discosoma sp. The constructs were transfected into HEK-293 cells individually or simultaneously, and the localization of the fusion proteins was visualized by fluorescence microscopy. The results demonstrated that both IR-EGFP-∆N 11-75 ( Figure 2G ) and IRRed2∆C 82-1023 ( Figure 2H) showed a non-ambiguous distribution to the cell membrane, although the receptors were also found intracellularly as clusters that were possibly associated with intracellular compartments or vesicles. This was in clear contrast to the cytoplasmic distribution observed for the lacZ deletions EGFP-∆N 11-75 ( Figure  2I ) and Red2-∆C 82-1023 ( Figure 2J ). It is worth mentioning that the insertion of EGFP and Red2 into the receptor constructs did not lead to a destruction of the enzymatic β-gal complex because the addition of X-gal still resulted in blue-stained cells (data not shown). This feature allows us to analyze simultaneously both the dimerization and localization in a single cell.
α α 2c AR and D2DR L Dimerization Monitored by Using β β-Gal Complementation
We further characterized the assay system by using it to investigate the protein-protein interactions of GPCRs using α 2c AR and D2DR L as target genes. HEK-293 cells were co-transfected with equimolar amounts of α 2c AR-∆N 11-75 and α 2c AR-∆C 82-1023 or with D2DR L -∆N 11-75 and D2DR L -∆C 82-1023 simultaneously or individually, with non-fusion ∆N 11-75 and ∆C 82-1023 as negative controls. Only a few cells were stained blue in the presence of X-gal when both nonfusion ∆N 11-75 and ∆C 82-1023 constructs were co-expressed ( Figure 3B ). Fusion to α 2c AR elevated the number of blue-stained cells significantly (Figure 3A) . Similar but moderate increases were also observed for D2DR L fusions. The enzymatic reactions for D2DR L fusions were carried out for a longer time due to the weaker signal obtained from these constructs, but this did not change the major conclusions about either the homodimerization of the D2DR L or the applicability of the ∆N 11-75 and ∆C 82-1023 mutants in such assays. No β-gal activity could be detected when only one of the two chimeric constructs was expressed ( Figure 3, C and D) . FACS analysis and colormetric β-gal activity assay provided a more quantitative confirmation to this conclusion. Cell populations co-expressed with α 2c AR-or D2DR L -fused ∆N 11-75 and ∆C 82-1023 construct pairs showed a β-gal activity that was elevated from 10 (D2RD L ) to 100 times (α 2c AR) ( Figure 4A ). The colorimetric measurement of β-gal activity confirmed that the enzyme activity was elevated 10-fold (D2DR L ), 35 times (IR), and 125 times (α 2c AR), respectively, by the homodimerization of the fusion proteins compared to the non-fused ∆N 11-75 and ∆C 82-1023 pairs. No β-gal activity could be detected when only one of the two chimeric IR, α 2c AR, and D2DR L constructs were expressed ( Figure 4B) .
We also co-transfected fusion constructs for different target proteins to study how different membrane proteins interact with each other. A weak but significant level of β-gal reconstitution was observed when α 2c AR-∆C 82-1023 and IR-∆N 11-75 were co-expressed, in comparison to that of the non-fusion ∆C 82-1023 and ∆N 11-75 control ( Figure 3E ). This demonstrated that the contact between α 2c AR and IR was strong enough to mediate the α-complementation between the lacZ mutants. The same was found between D2DR L and IR, although to a lesser extent ( Figure 3E ). At this stage, we were uncertain whether the heterodimeric interactions between the three receptors had functional consequences.
Comparison of the number of bluestained cells suggested that the receptors IR, α 2c AR, and D2DR L would predominantly form homodimers rather than heterodimers with each other under the experimental conditions described here. It further demonstrated that the homodimeric interactions of IR, α 2c AR, and D2DR L were specific and to a large extent at least and not consequences of transmembrane protein overexpression.
Several lines of evidence suggested that constitutive oligomerization is a general feature of GPCRs (4). Such basal oligomerization has been reported for the β2-adrenergic (1,11), the dopamine D2 (20) , and the insulin (3) receptor. We treated the cells co-expressing the fusion receptors with their cognate ligands insulin, brimonidine, and dopamine, but we did not observe a difference in the induction of β-gal activity. The result suggested that the ligands did not change the constitutive dimerization state of IR, α 2c AR, and D2DR L under the described experimental conditions (data not shown).
In summary, we present results that a pair of novel lacZ complementation deletions can be used for monitoring interactions between proteins to which they are fused. We demonstrated proof of the principle using membrane pro- proteins. The system has been validated with membrane proteins that dimerize constitutively so far, but it also has the potential to be extended for monitoring ligand-induced interactions. The discovery of the novel peptides ∆C 82-1023 and ∆N 11-75 that can undergo complementation extended our knowledge about the interesting phenomena.
The novel peptides could serve as useful tools for exploring the molecular events in the complementation process.
